BOT - Anything but charting, page-9769

I agree with both of you @wot and @Grainofsand

It doesnt seem to be a commitment by BOT themselves (although im going to go look at E&P now)

But I don't see the harm in updating the market (especially after a dip) and getting eyes on us, you would think this gives more buying confidence

Something like 'marketing teams hired with history in biotech sales etc etc'

Im beginning to wonder if BOT actually want eyes on them.. and why wouldnt they? Have instos advised them to be discreet?

$80 mill, no debt, no royalties, successful sales in Japan, FDA approval. I'd be on every TV station telling people.

Im sure they know what theyre doing but I think alot of us agree it doesnt make sense, im sure it will slap us in the face soon enough.